Table 1 Patient characteristics
Characteristics | Patient-numbers (% of total (71) participants) |
|---|---|
(A) Sex | |
 Women | 45 (63.4%) |
 Men | 26 (36.6%) |
(B) Age | |
 Mean Value | 42.4 (range 21–63) |
 Standard deviation | 11.4 |
(C) Duration of taking antipsychotics | |
 < 180 days | 7 (9.9%) |
 180–365 days | 4 (5.6%) |
 > 365 days | 56 (78.9%) |
 Unknowna | 4 (5.6%) |
(D) Drugs | |
 Second generation antipsychotics (SGA) | 59 (83.1%) |
 First generation antipsychotics (FGA) | 22 (31.0%) |
 Combined administration of antipsychotics | 27 (38.0%) |
 BZP/Orexin receptor blockers/ramelteon | 52 (73.2%) |
 Antidepressants | 30 (42.3%) |
 Mood stabilizers | 16 (22.5%) |
 Anticholinergic drugs | 12 (16.9%) |
 Psychostimulants | 3 (4.2%) |